adamantane has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hidaka, T; Kubo, A; Nakayama, M; Sasaki, Y; Suzuki, H; Suzuki, Y; Takagi, M | 1 |
1 other study(ies) available for adamantane and Focal Segmental Glomerulosclerosis
Article | Year |
---|---|
Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases.
Topics: Adamantane; Antibodies, Antineutrophil Cytoplasmic; Bowman Capsule; Diabetic Nephropathies; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Doxorubicin; Female; Glomerulosclerosis, Focal Segmental; Humans; In Vitro Techniques; Kidney; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Microfilament Proteins; Nephritis; Podocytes; rhoA GTP-Binding Protein | 2020 |